Practice Pearls

EP. 1: Practice Pearl 1: Implementation Urgency & Pharmacy’s Role in Response to COVID-19
EP. 2: Practice Pearl 1: Automated IV Workflow System Benefits in Pharmacy’s Response to COVID-19
EP. 3: Practice Pearl 1: IV Infusion Pump Features Most Beneficial in General & During the Pandemic
EP. 4: Practice Pearl 1: Impact and Management of Drug Shortages During the Pandemic
EP. 5: Practice Pearl 2: Benefits and Challenges of In-House Compounding of IV Products
EP. 6: Practice Pearl 2: Premixed IV Solutions & Drug Reconstitution Systems Use & Impact
EP. 7: Practice Pearl 2: Infection Control Challenges Due to COVID-19—PPE
EP. 8: Practice Pearl 2: Infection Control Challenges Due to COVID-19—Barcoding Practices
EP. 9: Practice Pearl 3: COVID-19 Vaccine Rollout & Training Pharmacists to Be Vaccinators
EP. 10: Practice Pearl 3: Strategies Implemented for the Vaccination of Health Care Workers
EP. 11: Practice Pearl 3: Steps to Prevent Vaccine Dose Waste & the Education of Medical Staff
EP. 12: Practice Pearl 3: Unexpected Challenges with the COVID-19 Vaccine Rollout
EP. 13: Practice Pearl 3: Emerging Role of Pharmacists on the Front Line of Vaccine Administration
EP. 1: Practice Pearl #1 Introduction, Definition and Diagnosis of Neuroendocrine Tumors
EP. 2: Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
EP. 3: Practice Pearl 1 How NETs Treatment Landscape Has Evolved
EP. 4: Practice Pearl 2: Efficacy of the Somatostatin Analogues for NETs
EP. 5: Practice Pearl 2: Indications and Safety Data of the Somatostatin Analogues for NETs
EP. 6: Practice Pearl 2: Differences Among the Somatostatin Analogues for NETs
EP. 7: Practice Pearl 2: Choosing 1 Agent Over Another in the Management of NETs
EP. 8: Practice Pearl 2: Pharmacists’ Role in Managing Treatment for Patient With NETs
EP. 9: Practice Pearl 2: Various Preparations and Delivery Systems of Somatostatin Analogues for NETs
EP. 10: Practice Pearl 2: Home Injection Programs for the Treatment of NETs
EP. 11: Practice Pearl 2: Efficacy and Safety Data of Everolimus for NETs
EP. 12: Practice Pearl 2: Management of Stomatitis When Using Everolimus for NETs
EP. 13: Practice Pearl 2: The Role of Peptide Receptor Radionuclide Therapy for NETs
EP. 14: Practice Pearl 3: Challenges for Obtaining Therapeutic Agents on Formulary for NETs
EP. 15: Practice Pearl 3 Challenges in Obtaining Authorization for the Treatments for NETs
EP. 16: Practice Pearl 3 Challenges in the Management Among the Various Sites of NETs
EP. 17: Practice Pearl 3 Unmet Needs in the Treatment of Neuroendocrine Tumors
EP. 1: Overview of Venous Thromboembolism
EP. 2: Evolution of Therapies to Prevention of Venous Thromboembolism
EP. 3: Risks and Risk Factors Associated with VTE
EP. 4: Identifying the Rate of VTE Postdischarge
EP. 5: Practice Pearl 1: Tools Used for VTE Risk Assessment
EP. 6: Practice Pearl 1: ISTH Recommendations & Pharmacists’ Role in Identifying Risk of VTE
EP. 7: Practice Pearl 2: Review Guidelines for the Prevention of VTE
EP. 8: Practice Pearl 2: Review Guidelines for the Treatment of VTE
EP. 9: Practice Pearl 2: Review of the Direct Oral Anticoagulants for VTE
EP. 10: Practice Pearl 2: Dose Adjustments of DOACs for Obese or Renal Insufficiency
EP. 11: Practice Pearl 2: Review of Studies for Prevention of VTE
EP. 12: Practice Pearl 2: Risks and Benefits of the Role of DOACs for Prevention of VTE
EP. 13: Practice Pearl 3: Dosage Forms of Treatment for VTE Prevention
EP. 14: Practice Pearl 3: Challenges in Managing VTE
EP. 1: Introduction and Overview of Direct Oral Anticoagulants
EP. 2: Review of Direct Oral Anticoagulants
EP. 3: Dosing of Direct Oral Anticoagulants
EP. 4: Practice Pearl #1 Definition of Obesity as Defined by CDC
EP. 5: Practice Pearl #1: International Society on Thrombosis and Haemostasis Statement
EP. 6: Practice Pearl #1: Personal Insight and Implications ISTH Statement
EP. 7: Practice Pearl #1: Risks and Benefits of Warfarin
EP. 8: Practice Pearl #1: Published Data With DOACs in Obese Patients
EP. 9: Practice Pearl #1: Data Using DOACs in Obese Patients With VTE
EP. 10: Practice Pearl #1: No Dose Adjustment Required for Weight
EP. 11: Practice Pearl #2 Challenges in Using DOACs in Obese Patients and Education
EP. 12: Practice Pearl #2 Lab Monitoring with DOACs
EP. 13: Practice Pearl #2 Monitoring for Efficacy of DOACs
EP. 14: Final Thoughts on DOACs in Obese Patients
EP. 1: Overview of Acute Myeloid Leukemia
EP. 2: Risk Factors for the Development of AML
EP. 3: Practice Pearl 1: Diagnosing Acute Myeloid Leukemia
EP. 4: Practice Pearl 1: The Importance of Cytogenetic Results in AML
EP. 5: Practice Pearl 1: Categorizing Patients for Treatment in AML
EP. 6: Practice Pearl 2: Inpatient and Outpatient Formulary Treatments for AML
EP. 7: Practice Pearl 2: P&T Committee for AML Treatments
EP. 8: Practice Pearl 2: Safety Precautions With AML Treatments
EP. 9: Practice Pearl 2: Medical Utilization Evaluation of Patients With AML
EP. 10: Inpatient Versus Outpatient Treatment in AML
EP. 11: Role of the Pharmacist in AML Outpatient Treatment
EP. 12: Impact of AML Outpatient Treatment on Quality of Life
EP. 13: IPOP Induction for Patients With AML
EP. 14: Acute Myeloid Leukemia Practice Pearls: Key Points in Pathway Identification
EP. 15: Acute Myeloid Leukemia Practice Pearls: Considerations for Formulary Decisions
EP. 1: Best Practices for the Treatment of Hemophilia
EP. 2: Overview, Diagnosis, and Complications of Hemophilia
EP. 3: Practice Pearl 1: Determining Severity and Goals of Therapy
EP. 4: Practice Pearl 1: Identifying Patients and Regimens for Prophylaxis
EP. 5: Practice Pearl 2: Determining the Role of Factor VIII
EP. 6: Practice Pearl 2: Patient Factors for Other Treatments
EP. 7: Practice Pearl 2: Administration Concerns, Costs, and Risks
EP. 8: Practice Pearl 3: Procedure for Transitioning and Patient Education
EP. 9: Practice Pearl 3: Reviewing the Dispensing Process
EP. 10: Practice Pearl 3: Complications and Pain Management With Hemophilia
EP. 11: Practice Pearl 4: Calculating Doses for Individualized Treatment
EP. 12: Practice Pearl 4: Dosing Complications and Various Dosage Vials
EP. 13: Practice Pearl 4: Challenges in Treatments and Final Thoughts
EP. 14: Hemophilia Practice Pearls Takeaways: Determining Goals of Therapy
EP. 15: Hemophilia Practice Pearls: Best Practices, Treatment Costs